Amedeo Smart

Free Medical Literature Service



Bacterial Infections and Mycoses

  Free Subscription

Articles published in
Diagn Microbiol Infect Dis
    July 2023
  1. PALUCH M, Lleres-Vadeboin M, Poupet H, Chanard E, et al
    Multicenter evaluation of rapid antimicrobial susceptibility testing by VITEK(R)2 directly from positive blood culture.
    Diagn Microbiol Infect Dis. 2023;106:115950.
    >> Share

  2. YUAN L, Xia D, Zhou Q, Xu W, et al
    An evaluation of a multiplex PCR assay for the detection of Treponema pallidum, HSV-1, and HSV-2.
    Diagn Microbiol Infect Dis. 2023;106:115958.
    >> Share

  3. ZHU Q, Xu J, Chen X, Ren Y, et al
    Risk factors and molecular epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae.
    Diagn Microbiol Infect Dis. 2023;106:115955.
    >> Share

  4. ARSLAN E, Coskun MK, Cobanoglu S, Aslan MH, et al
    Effects of four antibiotics on Pseudomonas aeruginosa motility, biofilm formation, and biofilm-specific antibiotic resistance genes expression.
    Diagn Microbiol Infect Dis. 2023;106:115931.
    >> Share

    June 2023
  5. WANG Y, Zhang M, Huang M, Wang T, et al
    Detection of serum human neutrophil lipocalin is an effective biomarker for the diagnosis and monitoring of children with bacterial infection.
    Diagn Microbiol Infect Dis. 2023;106:115943.
    >> Share

  6. MABUGANA MC, Dias BDC, Muller EE, Kufa T, et al
    The evaluation of the Allplex BV molecular assay for the diagnosis of bacterial vaginosis in symptomatic South African females.
    Diagn Microbiol Infect Dis. 2023;106:115924.
    >> Share

  7. BARROSO MDV, da Silva CR, Benfatti LR, Gozi KS, et al
    Characterization of KPC-2-producing Klebsiella pneumoniae and affected patients of a pediatric hospital in Brazil.
    Diagn Microbiol Infect Dis. 2023;106:115932.
    >> Share

  8. AREND LNVS, Bergamo R, Rocha FB, Bail L, et al
    Dissemination of NDM-producing bacteria in Southern Brazil.
    Diagn Microbiol Infect Dis. 2023;106:115930.
    >> Share

  9. GAO L, Yang T, Zhang X, Lei W, et al
    Rapid detection of pulmonary nocardiosis by metagenomic next generation sequencing.
    Diagn Microbiol Infect Dis. 2023;106:115928.
    >> Share

    May 2023
  10. OBENG-NKRUMAH N, Hansen DS, Awuah-Mensah G, Blankson NK, et al
    High level of colonization with third-generation cephalosporin-resistant Enterobacterales in African community settings, Ghana.
    Diagn Microbiol Infect Dis. 2023;106:115918.
    >> Share

  11. ZELLNER AA, Hischebeth GT, Molitor E, Wirtz DC, et al
    Periprosthetic joint infection caused by kytococcus schroeteri: The first reported case and a review of the literature.
    Diagn Microbiol Infect Dis. 2023;106:115922.
    >> Share

    April 2023
  12. HUBLER CM, Carvalhaes CG, Castanheira M
    Recent increase in fluconazole-nonsusceptible Candida parapsilosis in a global surveillance with the expansion of the Erg11 Y132F genotype and a rapid detection method for this alteration.
    Diagn Microbiol Infect Dis. 2023;106:115957.
    >> Share

  13. KANWAR N, Harrison CJ, Pence MA, Qin X, et al
    Comparative in vitro antipseudomonal activity of ceftolozane/tazobactam against Pseudomonas aeruginosa isolates from children with cystic fibrosis.
    Diagn Microbiol Infect Dis. 2023;105:115904.
    >> Share

  14. SAFI AUR, Bendixen E, Rahman H, Khattak B, et al
    Molecular identification and differential proteomics of drug resistant Salmonella Typhi.
    Diagn Microbiol Infect Dis. 2023;105:115883.
    >> Share

  15. DE BEL A, Brouwers A, Verbeke F, Coorevits L, et al
    VIDAS3(R) TB-IGRA assay: evaluation of performance characteristics in a predominantly low risk, low incidence population.
    Diagn Microbiol Infect Dis. 2023;105:115885.
    >> Share

    March 2023
  16. DAFFINEE KE, O'Neill ET, Bleick CR, Williams G, et al
    Staphylococcal biofilm: penetration and bioavailability of vancomycin with or without rifampin.
    Diagn Microbiol Infect Dis. 2023;106:115947.
    >> Share

  17. KOETH LM, DiFranco-Fisher JM, Scangarella-Oman NE
    Analysis of the effect of urine on the in vitro activity of gepotidacin and levofloxacin against Escherichia coli, Staphylococcus epidermidis, and Staphylococcus saprophyticus.
    Diagn Microbiol Infect Dis. 2023;106:115946.
    >> Share

  18. ZHENG M, Wang Y, Ying X, Zhang P, et al
    Clinical utility of tuberculosis RNA in the rapid diagnosis of bone and joint tuberculosis.
    Diagn Microbiol Infect Dis. 2023;106:115941.
    >> Share

  19. GAVAZZI G, Meyrignac L, Zerhouni N, Bioteau C, et al
    Intrinsic values of procalcitonin in bacterial bloodstream infections in people aged 75 years and over: a retrospective study.
    Diagn Microbiol Infect Dis. 2023;105:115887.
    >> Share

  20. HUNKINS JJ, de-Moura VC, Eddy JJ, Daley CL, et al
    In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States.
    Diagn Microbiol Infect Dis. 2023;105:115882.
    >> Share

  21. HURT W, Stephenson J, Hutchinson J, Godbole G, et al
    A rare case of Salmonella Paratyphi C osteomyelitis: A genetic analysis and review of Salmonella osteomyelitis in England.
    Diagn Microbiol Infect Dis. 2023;105:115877.
    >> Share

  22. BAKTHAVATCHALAM YD, Basu S, Shankar A, Ramaiah S, et al
    Genomics and structural insight into the masking of gentamicin-resistance in clinical Burkholderia pseudomallei strain VB29710 from India.
    Diagn Microbiol Infect Dis. 2023;105:115878.
    >> Share

    February 2023
  23. ARMSTRONG D, Fisher S, Totten M, Parrish N, et al
    An analytic feasibility study of the BD MAX MDR-TB assay for testing of non-sputum specimens for detection of the Mycobacterium tuberculosis complex (MTBC) and isoniazid (INH) and rifampin (RIF) resistance.
    Diagn Microbiol Infect Dis. 2023;106:115925.
    >> Share

  24. MUNIER C, Dupieux C, Kolenda C, Ranc AG, et al
    Sensitivity of the PBP2a SA Culture Colony Test on shortly incubated subcultures of methicillin-resistant staphylococci from positive blood cultures.
    Diagn Microbiol Infect Dis. 2023;106:115917.
    >> Share

  25. SILVA NC, de Souza MC, Tonini MAL, Schuenck RP, et al
    Dissemination of methicillin-resistant Staphylococcus aureus USA300 ST8/PVL- positive in breast infections in a Brazilian region.
    Diagn Microbiol Infect Dis. 2023;106:115919.
    >> Share

  26. KUCUKOGLU O, Sariguzel FM, Koc AN, Parkan OM, et al
    Molecular epidemiology, virulence factors, and antifungal susceptibility of Candida inconspicua strains isolated from clinical samples in Turkey.
    Diagn Microbiol Infect Dis. 2023;106:115915.
    >> Share

  27. FLORES-VEGA VR, Lara-Zavala BA, Jarillo-Quijada MD, Fernandez-Vazquez JL, et al
    Burkholderia vietnamiensis causing infections in noncystic fibrosis patients in a tertiary care hospital in Mexico.
    Diagn Microbiol Infect Dis. 2023;105:115866.
    >> Share

  28. SU W, Ju L, Hua Q, Hu J, et al
    Values of combined C-reactive protein, procalcitonin and serum amyloid A in differential diagnosis of bacterial and non-bacterial community acquired pneumonia in children.
    Diagn Microbiol Infect Dis. 2023;105:115865.
    >> Share

  29. FREIRE S, Grilo T, Nordmann P, Poirel L, et al
    Multiplex PCR for detection of acquired plasmid-borne fosfomycin resistance fos genes in Escherichia coli.
    Diagn Microbiol Infect Dis. 2023;105:115864.
    >> Share

  30. LAROCHE L, Mercier V, Sasso M
    BD BACTEC Mycosis IC/F culture vials for fungemia diagnosis and follow-up: a retrospective study from 2013 to 2020.
    Diagn Microbiol Infect Dis. 2023;105:115863.
    >> Share

  31. MIENDJE DEYI VY, Ntounda R, Louis H, Kahegeshe NL, et al
    Primary Helicobacter pylori resistance to antimicrobials in the Brussels area in 2021.
    Diagn Microbiol Infect Dis. 2023;105:115855.
    >> Share

  32. DONNARS A, Mahieu R, Declerck C, Chenouard R, et al
    BIOFIRE(R) Blood Culture IDentification 2 (BCID2) panel for early adaptation of antimicrobial therapy in adult patients with bloodstream infections: a real-life experience.
    Diagn Microbiol Infect Dis. 2023;105:115858.
    >> Share

  33. LI L, Yuan Y, He W, Zheng L, et al
    Emerging multidrug resistance contributes to treatment failure in Mycoplasma genitalium infected patients in China.
    Diagn Microbiol Infect Dis. 2023;105:115854.
    >> Share

  34. KRAUSSER L, Braet SM, Benaamar Z, Van Dyck-Lippens M, et al
    Mycobacterium tuberculosis retains viability in RNAlater buffer but not in GTC-TCEP and DNA/RNA Shield.
    Diagn Microbiol Infect Dis. 2023;106:115905.
    >> Share

    January 2023
  35. LUO Y, Xue Y, Liu W, Song H, et al
    Convolutional neural network based on T-SPOT.TB assay promoting the discrimination between active tuberculosis and latent tuberculosis infection.
    Diagn Microbiol Infect Dis. 2023;105:115892.
    >> Share

  36. BRUNING AHL, Beld MVD, Laverge J, Welkers MRA, et al
    Reptile-associated Salmonella urinary tract infection: a case report.
    Diagn Microbiol Infect Dis. 2023;105:115889.
    >> Share

  37. SABIN AP, Scholze BP, Lovrich SD, Callister SM, et al
    Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin.
    Diagn Microbiol Infect Dis. 2023;105:115837.
    >> Share

  38. LEWIS AD, Bridwell MR, Hambuchen MD, Clay TB, et al
    Correlation of MRSA polymerase chain reaction (PCR) nasal swab in ventilator-associated pneumonia, lung abscess, and empyema.
    Diagn Microbiol Infect Dis. 2023;105:115836.
    >> Share

  39. ARISTIZABAL-HOYOS AM, Rodriguez EA, Torres-Palma RA, Jimenez JN, et al
    Concern levels of beta-lactamase-producing Gram-negative bacilli in hospital wastewater: hotspot of antimicrobial resistance in Latin-America.
    Diagn Microbiol Infect Dis. 2023;105:115819.
    >> Share

    December 2022
  40. GOTO R, Jin W, Wachino JI, Arakawa Y, et al
    Improved disk diffusion method for simple detection of group B streptococci with reduced penicillin susceptibility (PRGBS).
    Diagn Microbiol Infect Dis. 2022;105:115881.
    >> Share

  41. SOOD M, Sharma S, Sood S, Sharma V, et al
    Diagnostic accuracy of urine based lipoarabinomannan point of care tuberculosis diagnostic test in HIV negative children: a systematic review and meta-analysis.
    Diagn Microbiol Infect Dis. 2022;105:115879.
    >> Share

  42. TSUNEOKA H, Otsuyama KI, Hirano A, Nojima J, et al
    Clinical utility of indirect fluorescent assay for IgA class antibodies against Bartonella henselae in serodiagnosis of cat scratch disease in its early stage.
    Diagn Microbiol Infect Dis. 2022;104:115809.
    >> Share

  43. SANCHEZ NO, Perez NF, Martinez SB
    Evaluation of the viasure Neisseria gonorrhoeae ciprofloxacin resistant assay for the simultaneous identification and direct detection of ciprofloxacin susceptibility.
    Diagn Microbiol Infect Dis. 2022;104:115798.
    >> Share

  44. HUANG HY, Chang YT, Lu PL, Yang TY, et al
    Correlation of Vitek 2 and Agar dilution for levofloxacin susceptibility testing and clinical outcomes of Enterobacterales bacteremia with 2019 CLSI breakpoints.
    Diagn Microbiol Infect Dis. 2022;104:115799.
    >> Share

  45. PFALLER M, Mendes RE, Streit JM, Carvalhaes CG, et al
    Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA, Europe, Latin America, and the Asia-Pacific region (2015-2019).
    Diagn Microbiol Infect Dis. 2022;104:115804.
    >> Share

  46. GARCIA-RIVERA C, Parra-Grande M, Merino E, Boix V, et al
    Concordance of the filmarray blood culture identification panel 2 and classical microbiological methods in a bacteriemia diagnostic unit.
    Diagn Microbiol Infect Dis. 2022;104:115787.
    >> Share

  47. XIA D, Yuan L, Zhou Q, Chen S, et al
    Performance evaluation of eight treponemal antibody tests in China.
    Diagn Microbiol Infect Dis. 2022;104:115790.
    >> Share

  48. KUO P, LeCrone K, Chiu M, Realegeno S, et al
    Analysis of the FAST system for expedited identification and antimicrobial susceptibility testing of bloodborne pathogens.
    Diagn Microbiol Infect Dis. 2022;104:115783.
    >> Share

    November 2022
  49. PINHATA JMW, Brandao AP, Gallo JF, Oliveira RS, et al
    GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory.
    Diagn Microbiol Infect Dis. 2022;105:115856.
    >> Share

  50. LEROY AG, Robert M, Carpentier M, Bastidon C, et al
    Assessment of a fully automated RPR assay (Mediace RPR) for serological diagnosis and follow-up of syphilis: a retrospective study.
    Diagn Microbiol Infect Dis. 2022;104:115767.
    >> Share

  51. BALLABEN AS, Galetti R, Ferreira JC, Paziani MH, et al
    Different virulence genetic context of multidrug-resistant CTX-M- and KPC-producing Klebsiella pneumoniae isolated from cerebrospinal fluid.
    Diagn Microbiol Infect Dis. 2022;104:115784.
    >> Share

  52. MCCARTY TP, White CM, Meeder J, Moates D, et al
    Analytical performance and potential clinical utility of the GenMark Dx ePlex(R) blood culture identification gram-positive panel.
    Diagn Microbiol Infect Dis. 2022;104:115762.
    >> Share

  53. YOSHIDA S, Tsuyuguchi K, Kobayashi T, Shimatani Y, et al
    Effect of sputum quality on Mycobacterium avium-intracellulare complex lung disease diagnosis and treatment initiation according to disease type.
    Diagn Microbiol Infect Dis. 2022;104:115773.
    >> Share

  54. PIETIKAINEN A, Glader O, Kortela E, Kanerva M, et al
    Borrelia burgdorferi specific serum and cerebrospinal fluid antibodies in Lyme neuroborreliosis.
    Diagn Microbiol Infect Dis. 2022;104:115782.
    >> Share

    October 2022
  55. SASAKI T, Doi Y
    Staphylococcus lugdunensis bacteremia: clinical implications of single set positive blood cultures.
    Diagn Microbiol Infect Dis. 2022;105:115835.
    >> Share

  56. LIM YK, Kweon OJ, Kim HR, Kim TH, et al
    Comparison of simulated candidemia detection during prophylactic antifungal therapy.
    Diagn Microbiol Infect Dis. 2022;104:115768.
    >> Share

  57. PRUSSING C, Southwick K, Snavely E, Kidney A, et al
    Comparative analysis of multiplexed PCR and short- and long-read whole genome sequencing to investigate a large Klebsiella pneumoniae outbreak in New York State.
    Diagn Microbiol Infect Dis. 2022;104:115765.
    >> Share

  58. ZHAO J, Lu B, Zhou Y, Wang S, et al
    Molecular identification and clinical significance of Mycobacterium seoulense strains from patients with nontuberculous mycobacterium infections.
    Diagn Microbiol Infect Dis. 2022;104:115756.
    >> Share

  59. MENTULA S, Paakkanen J, Hyyrylainen HL
    External quality assessment by European mycobacterial laboratories: results of AFB microscopy and identification rounds.
    Diagn Microbiol Infect Dis. 2022;104:115757.
    >> Share

    September 2022
  60. SADER HS, Castanheira M, Duncan LR, Mendes RE, et al
    Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018-2020).
    Diagn Microbiol Infect Dis. 2022;105:115820.
    >> Share

  61. KHRULNOVA S, Fedorova A, Frolova I, Tandilova K, et al
    Distribution of virulence genes and capsule types in Klebsiella pneumoniae among bloodstream isolates from patients with hematological malignancies.
    Diagn Microbiol Infect Dis. 2022;104:115744.
    >> Share

  62. BOYANOVA L, Kandilarov N, Hadzhiyski P, Gergova R, et al
    Increase in amoxicillin resistance in Helicobacter pylori from Bulgarian patients over 15 years.
    Diagn Microbiol Infect Dis. 2022;104:115746.
    >> Share

  63. DURSKI M, Ravel J, Spautz ACPG, Carvalho NS, et al
    Comparison of two microscopic interpretations of vaginal microbiota with molecular profiling.
    Diagn Microbiol Infect Dis. 2022;104:115728.
    >> Share

    August 2022
  64. GO JR, Baddour LM, Lahr BD, Sohail MR, et al
    The skip phenomenon in Staphylococcus aureus bacteremia: clinical implications.
    Diagn Microbiol Infect Dis. 2022;104:115802.
    >> Share

  65. ARONIN SI, Dunne MW, Yu KC, Watts JA, et al
    Increased rates of extended-spectrum beta-lactamase isolates in patients hospitalized with culture-positive urinary Enterobacterales in the United States: 2011 - 2020.
    Diagn Microbiol Infect Dis. 2022;103:115717.
    >> Share

  66. COWMAN K, Rossi J, Gendlina I, Guo Y, et al
    Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients.
    Diagn Microbiol Infect Dis. 2022;103:115721.
    >> Share

    July 2022
  67. LAUPLAND KB, Harris PNA, Stewart AG, Edwards F, et al
    Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections.
    Diagn Microbiol Infect Dis. 2022;104:115772.
    >> Share

  68. DAHAN NASSY S, Azrad M, Abozaid S, Glikman D, et al
    Assessing the impact of a positive Biofire(R) FilmArray(R) Meningitis/Encephalitis Panel result on clinical management and outcomes.
    Diagn Microbiol Infect Dis. 2022;104:115769.
    >> Share

  69. BRIDWELL MR, Bajaj S, Gress TW, Hambuchen MD, et al
    Impact of MRSA polymerase chain reaction (PCR) wound swabs on antibiotic de-escalation in skin and soft tissue infections.
    Diagn Microbiol Infect Dis. 2022;103:115722.
    >> Share

  70. ANNE-GAELLE R, Celia S, Jeanne C, Frederic B, et al
    Performances of the BD MAX CDIFF assay for the detection of toxigenic Clostridioides difficile using Cary-Blair preserved samples.
    Diagn Microbiol Infect Dis. 2022;103:115701.
    >> Share

  71. YOO IY, Shin DP, Heo W, Ha SI, et al
    Comparison of BD MAX Check-Points CPO assay with Cepheid Xpert Carba-R assay for the detection of carbapenemase-producing Enterobacteriaceae directly from rectal swabs.
    Diagn Microbiol Infect Dis. 2022;103:115716.
    >> Share

  72. VAILLANT JJ, Cunningham SA, Patel R
    Antibiotic susceptibility testing of Staphylococcus aureus using the Biolog OmniLog(R) system, a metabolic phenotyping assay.
    Diagn Microbiol Infect Dis. 2022;104:115759.
    >> Share

    June 2022
  73. KOBAYASHI Y, Shibata S, Yagi T
    Molecular epidemiology and antimicrobial susceptibility profiles of Campylobacter jejuni isolated from bloodstream infections and enteritis in Japan.
    Diagn Microbiol Infect Dis. 2022;103:115681.
    >> Share

    May 2022
  74. CLOSE RM, Sutcliffe CG, Galdun P, Reid A, et al
    Point-of-care molecular diagnostics for the detection of group A Streptococcus in non-invasive skin and soft tissue infections: a validation study.
    Diagn Microbiol Infect Dis. 2022;103:115729.
    >> Share

  75. YU HJ, Kim TY, Shim HJ, Yun SA, et al
    Comparison between the STANDARD F S. Pneumoniae Ag FIA and BinaxNOW S. Pneumoniae Antigen Card for Detection of Streptococcus Pneumoniae Urinary Antigen.
    Diagn Microbiol Infect Dis. 2022;104:115725.
    >> Share

  76. YAMADA T, Minami K, Oda K, Suzuki K, et al
    Probability of target attainment of oral antimicrobials for Escherichia coli and Klebsiella pneumoniae based on Monte Carlo simulations.
    Diagn Microbiol Infect Dis. 2022;103:115662.
    >> Share

  77. KHODER M, Rafei R, Osman M, Kassem II, et al
    Emergence of a Neisseria flavescens clinical strain with a high level of third-generation cephalosporins resistance in Lebanon.
    Diagn Microbiol Infect Dis. 2022;103:115660.
    >> Share

  78. ZHU X, Zhao Y, Zhu C, Wang Y, et al
    Rapid detection of cagA-positive Helicobacter pylori based on duplex recombinase aided amplification combined with lateral flow dipstick assay.
    Diagn Microbiol Infect Dis. 2022;103:115661.
    >> Share

  79. PIETIKAINEN A, Backman I, Henningsson AJ, Hytonen J, et al
    Clinical performance and analytical accuracy of a C6 peptide-based point-of-care lateral flow immunoassay in Lyme borreliosis serology.
    Diagn Microbiol Infect Dis. 2022;103:115657.
    >> Share

    April 2022
  80. DIENSTHUBER D, Simnacher U, Peters S, Walther P, et al
    Clearing Chlamydia abortus infection in epithelial cells and primary human macrophages by use of antibiotics and the MDM2-p53-inhibitor nutlin-3.
    Diagn Microbiol Infect Dis. 2022;103:115715.
    >> Share

  81. AONO A, Murase Y, Chikamatsu K, Igarashi Y, et al
    In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis: a comparative study using microdilution broth assay and genomics.
    Diagn Microbiol Infect Dis. 2022;103:115714.
    >> Share

  82. ROSTAMIAN M, Kooti S, Mohammadi B, Salimi Y, et al
    A systematic review and meta-analysis of Listeria monocytogenes isolated from human and non-human sources: the antibiotic susceptibility aspect.
    Diagn Microbiol Infect Dis. 2022;102:115634.
    >> Share

  83. YOSHIMURA M, Tokushige C, Maruyama JI, Kawano Y, et al
    Emerging resistance to beta-lactams in Pantoea ananatis isolated from an immunocompetent patient with bacteremia.
    Diagn Microbiol Infect Dis. 2022;102:115633.
    >> Share

  84. PRINCE HE, Batterman HJ, Realegeno SE, Marlowe EM, et al
    Transience of interference in an immunoassay measuring serum levels of beta-D-glucan.
    Diagn Microbiol Infect Dis. 2022;102:115630.
    >> Share

  85. PFALLER MA, Carvalhaes CG, DeVries S, Huband MD, et al
    Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019.
    Diagn Microbiol Infect Dis. 2022;102:115627.
    >> Share

    March 2022
  86. SAVINOVA T, Bocharova Y, Mayanskiy N, Chebotar I, et al
    Genetic determinants of virulence and antibiotic resistance are common for Pseudomonas aeruginosa ST235 isolates from cystic fibrosis patients from various geographical regions.
    Diagn Microbiol Infect Dis. 2022;102:115596.
    >> Share

    February 2022
  87. BOSCHIERO MN, Duarte A, Palamim CVC, Alvarez AE, et al
    Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing.
    Diagn Microbiol Infect Dis. 2022;102:115576.
    >> Share

  88. SUN Y, Shukla MR, Deutsch J, Cao W, et al
    Evaluation of the effect of extended refrigerated storage of serum and plasma specimens on syphilis serologic test results.
    Diagn Microbiol Infect Dis. 2022;102:115588.
    >> Share

  89. MELENDEZ JH, Chen FE, Wang TH
    Antimicrobial susceptibility testing of Neisseria gonorrhoeae using a phenotypic-molecular assay and lyophilized antimicrobials.
    Diagn Microbiol Infect Dis. 2022;102:115590.
    >> Share

  90. ROSSATO L, Arantes JP, Ribeiro SM, Simionatto S, et al
    Antibacterial activity of gallium nitrate against polymyxin-resistant Klebsiella pneumoniae strains.
    Diagn Microbiol Infect Dis. 2022;102:115569.
    >> Share

    January 2022
  91. BOLKER A, Coe K, Smith J, Stevenson K, et al
    Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients.
    Diagn Microbiol Infect Dis. 2022;102:115558.
    >> Share

  92. SADER HS, Mendes RE, Streit JM, Carvalhaes CG, et al
    Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020).
    Diagn Microbiol Infect Dis. 2022;102:115557.
    >> Share

    A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease.
    Diagn Microbiol Infect Dis. 2022;102:115572.
    >> Share

    December 2021
  94. MEEX C, Devey A, Defeche J, Bontems S, et al
    Evaluation of the Revogene(R) GBS DS assay performance for the intrapartum screening of group B streptococcus in comparison with intrapartum culture.
    Diagn Microbiol Infect Dis. 2021;102:115616.
    >> Share

  95. DE BENEDETTO I, Boglione L
    Reply to: impact of Chronic Hepatitis C virus co-infection on outcomes of infective endocarditis in people who inject drugs.
    Diagn Microbiol Infect Dis. 2021;102:115615.
    >> Share

  96. CHOI H, Hwang M, Chatterjee P, Jinadatha C, et al
    Rare Lelliottia nimipressuralis from a wound infection case report using whole genome sequencing-based bacterial identification.
    Diagn Microbiol Infect Dis. 2021;101:115538.
    >> Share

  97. HU S, Lv Z, Wang Y, Shen J, et al
    Novel Quadruplex PCR for detecting and genotyping mobile colistin resistance genes in human samples.
    Diagn Microbiol Infect Dis. 2021;101:115419.
    >> Share

  98. BUTCHER M, Puiu D, Romagnoli M, Carroll KC, et al
    Rapidly fatal infection with Bacillus cereus/thuringiensis: genome assembly of the responsible pathogen and consideration of possibly contributing toxins.
    Diagn Microbiol Infect Dis. 2021;101:115534.
    >> Share

  99. WOODSON EN, Katz SS, Mosley SS, Danavall DC, et al
    Use of real-time PCR as an alternative to conventional genotyping methods for the laboratory detection of lymphogranuloma venereum (LGV).
    Diagn Microbiol Infect Dis. 2021;101:115532.
    >> Share

  100. BOUSSI LS, Popli T, Feola N, Nog R, et al
    Clinical and microbiological characteristics of patients with bacteremia and normal procalcitonin.
    Diagn Microbiol Infect Dis. 2021;101:115515.
    >> Share

  101. SADEK M, Poirel L, Dominguez Pino M, D'Emidio F, et al
    Evaluation of SuperCAZ/AVI(R) Medium for Screening Ceftazidime-avibactam Resistant Gram-negative Isolates.
    Diagn Microbiol Infect Dis. 2021;101:115475.
    >> Share

  102. SCANGARELLA-OMAN NE, Dixon P, Koeth LM, DiFranco-Fisher J, et al
    Analysis of antimicrobial susceptibility testing methods and variables and in vitro activity of gepotidacin against urogenital Neisseria gonorrhoeae in men.
    Diagn Microbiol Infect Dis. 2021;101:115484.
    >> Share

  103. SENCHYNA F, Tamburini FB, Murugesan K, Watz N, et al
    Comparative genomics of Enterobacter cloacae complex before and after acquired clinical resistance to Ceftazidime-Avibactam.
    Diagn Microbiol Infect Dis. 2021;101:115511.
    >> Share

  104. HOVAN MR, Narayanan N, Cedarbaum V, Bhowmick T, et al
    Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia.
    Diagn Microbiol Infect Dis. 2021;101:115505.
    >> Share

  105. AKAPELWA ML, Kapalamula TF, Ouchi-Aizu Y, Hang'ombe BM, et al
    Evaluation of IS1245 LAMP in Mycobacterium avium and the influence of host-related genetic diversity on its application.
    Diagn Microbiol Infect Dis. 2021;101:115494.
    >> Share

    November 2021
  106. HEIREMAN L, Bruynseels P, Camps K, Geysels D, et al
    Comparison of the QuantiFERON-TB(R) Gold Plus on LIAISON(R) XL and T-SPOT.TB for the diagnosis of latent Mycobacterium tuberculosis infection in a low tuberculosis incidence population.
    Diagn Microbiol Infect Dis. 2021;102:115613.
    >> Share

  107. LOPEZ-PINTOR JM, Martinez-Garcia L, Maruri A, Menendez B, et al
    Quantification of plasmid copy number as surrogate marker of virulence among different invasive and non-invasive genotypes of Chlamydia trachomatis.
    Diagn Microbiol Infect Dis. 2021;102:115610.
    >> Share

  108. MCCREERY R, Nielsen L, Clarey D, Murphy C, et al
    Evaluation of cerebrospinal fluid white blood cell count criteria for use of the BioFire(R) FilmArray(R) Meningitis/Encephalitis Panel in immunocompromised and nonimmunocompromised patients.
    Diagn Microbiol Infect Dis. 2021;102:115605.
    >> Share

  109. JIANG X, Zhu L, Zhan D
    Development of a recombinase polymerase amplification assay for rapid detection of Streptococcus suis type 2 in nasopharyngeal swab samples.
    Diagn Microbiol Infect Dis. 2021;102:115594.
    >> Share

  110. ZAMORA-CINTAS MI, Lopez DJ, Blanco AC, Rodriguez TM, et al
    Coinfections among hospitalized patients with covid-19 in the first pandemic wave.
    Diagn Microbiol Infect Dis. 2021;101:115416.
    >> Share

  111. NOVY E, Goury A, Thivilier C, Guillard T, et al
    Algorithm for rational use of Film Array Pneumonia Panel in bacterial coinfections of critically ill ventilated COVID-19 patients.
    Diagn Microbiol Infect Dis. 2021;101:115507.
    >> Share

  112. RUIZ-BASTIAN M, Falces-Romero I, Ramos-Ramos JC, de Pablos M, et al
    Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: Surfing the first wave.
    Diagn Microbiol Infect Dis. 2021;101:115477.
    >> Share

  113. TIMBROOK TT, Hueth KD, Ginocchio CC
    Identification of bacterial co-detections in COVID-19 critically Ill patients by BioFire(R) FilmArray(R) pneumonia panel: a systematic review and meta-analysis.
    Diagn Microbiol Infect Dis. 2021;101:115476.
    >> Share

  114. UGABAN KB, She RC
    The clinical significance of staphylococcus pettenkoferi: a retrospective review at a tertiary care medical center.
    Diagn Microbiol Infect Dis. 2021;102:115592.
    >> Share

  115. YONETANI S, Hirao C, Ohnishi H
    Background of patients with Aerococcus spp. detected in blood cultures, and drug sensitivity of Aerococcus spp.
    Diagn Microbiol Infect Dis. 2021;101:115506.
    >> Share

  116. DIEZ A, Carrano G, Bregon-Villahoz M, Cuetara MS, et al
    Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients.
    Diagn Microbiol Infect Dis. 2021;101:115509.
    >> Share

  117. RUSSELLO G, Moramarco A, Vizzini L, Farina C, et al
    Diagnostic approach and epidemiology of Microbial Keratitis: findings from an Italian Tertiary Care center.
    Diagn Microbiol Infect Dis. 2021;101:115470.
    >> Share

  118. PFALLER MA, Carvalhaes CG, Messer SA, Rhomberg PR, et al
    In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
    Diagn Microbiol Infect Dis. 2021;101:115473.
    >> Share

  119. VALIATTI TB, Santos FF, Nunes PHS, Cayo R, et al
    Characterization of virulent Klebsiella variicola recovered from inpatients with intestinal and extraintestinal infections between 1987 and 1999.
    Diagn Microbiol Infect Dis. 2021;101:115482.
    >> Share

  120. PHILLIPS TR, Tabesh M, Fairley CK, Maddaford K, et al
    A comparison of cotton-tipped and nylon flocked swabs for culture of Neisseria gonorrhoeae from oropharyngeal samples.
    Diagn Microbiol Infect Dis. 2021;101:115455.
    >> Share

  121. LIN BB, Pattle N, Kelley P, Jaksic AS, et al
    Multiplex RT-PCR provides improved diagnosis of skin and nail dermatophyte infections compared to microscopy and culture: a laboratory study and review of the literature.
    Diagn Microbiol Infect Dis. 2021;101:115413.
    >> Share

    October 2021
  122. MORRISON AR, Jones MC, Makowski CT, Samuel LP, et al
    Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis.
    Diagn Microbiol Infect Dis. 2021;102:115571.
    >> Share

  123. QUIRINO A, Marascio N, Peronace C, Gallo L, et al
    Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes.
    Diagn Microbiol Infect Dis. 2021;101:115485.
    >> Share

  124. JOSHI P, Shrivastava R, Bhagwat S, Patel M, et al
    Activity of beta-lactam plus beta-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
    Diagn Microbiol Infect Dis. 2021;101:115481.
    >> Share

  125. MALCZYNSKI M, Zhu A, Zembower T, Qi C, et al
    Diagnostic performance of Ion 16S metagenomics kit and Ion reporter metagenomics workflow for bacterial pathogen detection in culture-negative clinical specimens from sterile sources.
    Diagn Microbiol Infect Dis. 2021;101:115451.
    >> Share

  126. JOHNSTON MM, Huang V, Hall ST, Buckley MS, et al
    Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?
    Diagn Microbiol Infect Dis. 2021;101:115442.
    >> Share

  127. GOLDEN AR, Fear T, Baxter M, Adam HJ, et al
    Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018.
    Diagn Microbiol Infect Dis. 2021;101:115447.
    >> Share

  128. PARMELAND L, Bourru T, Kyungu V, Rousseau N, et al
    A rapid and inexpensive protocol to screen for third generation cephalosporin-resistant and non-fermenting Gram-negative rods directly in positive blood cultures.
    Diagn Microbiol Infect Dis. 2021;101:115428.
    >> Share

  129. NOVAL M, Heil EL, Williams P, Johnson JK, et al
    The potential impact of discrepancies between automated susceptibility platforms and other testing metho`dologies for cefazolin in the treatment of Enterobacterales bloodstream infections.
    Diagn Microbiol Infect Dis. 2021;101:115483.
    >> Share

  130. WORMSER GP, Strle F, Shapiro ED, Auwaerter PG, et al
    Comparison of the clinical practice guidelines for Lyme disease from the Infectious Diseases Society of America: 2000, 2006, and 2020.
    Diagn Microbiol Infect Dis. 2021;101:115446.
    >> Share

  131. CLEMMONS AB, Young HN, Bland CM, Jackson B, et al
    Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia.
    Diagn Microbiol Infect Dis. 2021;101:115444.
    >> Share

    September 2021
  132. HIYAMA Y, Sato T, Takahashi S, Yamamoto S, et al
    Reduction of susceptibility to azoles and 5-fluorocytosine and growth acceleration in Candida albicans in glucosuria.
    Diagn Microbiol Infect Dis. 2021;102:115556.
    >> Share

  133. GARCIA-CABALLERO A, de Dios Caballero J, Maruri A, Serrano-Tomas MI, et al
    Evaluation of different phenotypic methods to detect methicillin resistance in Staphylococcus aureus isolates recovered from cystic fibrosis patients.
    Diagn Microbiol Infect Dis. 2021;102:115559.
    >> Share

  134. XIA XJ, Zhong Y, Sang B, Li QP, et al
    Violet colonies of Talaromyces marneffei produce on CHROMagar candida medium.
    Diagn Microbiol Infect Dis. 2021;101:115533.
    >> Share

  135. KUFEL WD, Mastro KA, Steele JM, Wang D, et al
    Impact of a pharmacist-facilitated, evidence-based bundle initiative on Staphylococcus aureus bacteremia management.
    Diagn Microbiol Infect Dis. 2021;101:115535.
    >> Share

  136. ROSALES-REYES R, Esposito F, Fontana H, Lezana-Fernandez JL, et al
    Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection.
    Diagn Microbiol Infect Dis. 2021;101:115454.
    >> Share

  137. ITO A, Ishida T, Tachibana H, Nakanishi Y, et al
    Predictors and usefulness of targeted therapy for pneumococcal community-acquired pneumonia diagnosed by the urinary antigen test: a prospective, observational cohort study.
    Diagn Microbiol Infect Dis. 2021;101:115457.
    >> Share

  138. VAN DEN MUNCKHOF EHA, van Sitter RL, Lamont RF, le Cessie S, et al
    Developing an algorithm for the diagnosis of abnormal vaginal discharge in a dutch clinical setting: a pilot study.
    Diagn Microbiol Infect Dis. 2021;101:115431.
    >> Share

    Documentation of a false positive Lyme disease serologic test in a patient with untreated Babesia microti infection carries implications for accurately determining the frequency of Lyme disease coinfections.
    Diagn Microbiol Infect Dis. 2021;101:115429.
    >> Share

  140. MAHAJAN N, Sood S, Das BK, Kapil A, et al
    Molecular characterization of decreased susceptibility to ceftriaxone and genotyping of Neisseria gonorrheae isolates in New Delhi, India.
    Diagn Microbiol Infect Dis. 2021;101:115423.
    >> Share

  141. TICKLER IA, Shettima SA, Dela Cruz CM, Le VM, et al
    Characterization of carbapenem-resistant gram-negative bacterial isolates from Nigeria by whole genome sequencing.
    Diagn Microbiol Infect Dis. 2021;101:115422.
    >> Share

  142. WALKTY A, Karlowsky JA, Baxter MR, Adam HJ, et al
    In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD study, 2016-2019.
    Diagn Microbiol Infect Dis. 2021;101:115418.
    >> Share

  143. KRISTOF K, Adamkova V, Adler A, Gospodarek-Komkowska E, et al
    In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014-2017 and 2018.
    Diagn Microbiol Infect Dis. 2021;101:115420.
    >> Share

  144. SONG J, Kim S, Park J, Park Y, et al
    Comparison of two beta-D-glucan assays for detecting invasive fungal diseases in immunocompromised patients.
    Diagn Microbiol Infect Dis. 2021;101:115415.
    >> Share

    August 2021
  145. ZHANG CY, Zhang HH, Zhao SL, Wu HY, et al
    Clinical value of alkaline phosphatase on the surface membrane of neutrophils for prediction of bacteremia in patients with systemic inflammatory response syndrome.
    Diagn Microbiol Infect Dis. 2021;100:114105.
    >> Share

  146. BIBBOLINO G, Di Lella FM, Oliva A, Lichtner M, et al
    Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-2019.
    Diagn Microbiol Infect Dis. 2021;100:115399.
    >> Share

  147. CLAY TB, Orwig KW, Stevens RA, Davis EP, et al
    Correlation of MRSA polymerase chain reaction (PCR) wound swab testing and wound cultures in skin and soft tissue infections.
    Diagn Microbiol Infect Dis. 2021;100:115389.
    >> Share

    July 2021
  148. SAPOZHNIKOV J, Huang A, Zeeck K, Gibble A, et al
    Comparison of outcomes in urinary tract infections caused by AmpC-harboring organisms treated with AmpC stable versus AmpC susceptible agents.
    Diagn Microbiol Infect Dis. 2021;101:115472.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016